The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Australian manufacturers of therapeutic goods (medicines, active pharmaceutical ingredients (APIs) and biologicals, human blood and blood components and haematopoietic progenitor cells) must apply for a manufacturing licence for an Australian manufacturing site.
For details go to Australian manufacturing licences and overseas GMP certification.